http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2575372-B2

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
filingDate 1987-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1997-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2575372-B2
titleOfInvention Anticancer agent
priorityDate 1987-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417860949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44630766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673786
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151383743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426273090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449392513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414858464

Total number of triples: 27.